A case report of COVID-19 positive Becker Muscular Dystrophy

Authors

  • Lakshmi Prasanna Digala MD University of Missouri Health Care
  • Shivika Prasanna MS
  • Praveen Rao PhD
  • Adnan Qureshi MD
  • Raghav Govindarajan MD

DOI:

https://doi.org/10.17161/rrnmf.v2i5.15505

Keywords:

Becker Muscular Dystrophy, COVID-19 infection, Muscular dystrophy.

Abstract

Background:

Becker and Duchenne muscular dystrophies constitute the most common inherited dystrophinopathies. The chronic steroid treatment predisposes them to any infection, hence, we sought to determine the current COVID-19 infection in them. We conducted an analysis on a real-world database to identify the effect of COVID-19 infection and identified a case of Becker muscular dystrophy who tested positive for COVID-19. For our analysis, we utilized Cerner Real-World DataTM that was provided through Cerner's HealtheDataLab research tool.

Case report:

 A 63-year-old Caucasian male with Becker muscular dystrophy, hyperlipidemia, and atrial fibrillation, was hospitalized with COVID-19 infection. Our search revealed June 22, 2020, as the patient's COVID-19 service date when tested positive. The patient received antibiotics and supportive therapy during hospitalization. Intricate details like oxygen requirement, blood gas analysis, and mechanical ventilation could not be retrieved if used. The patient developed complications like sepsis, pneumonia, acute respiratory failure that resulted in prolonged hospitalization. Our data reported that the patient was alive during discharge.

Conclusion:

 Although patient developed complications during hospitalization, no death from the COVID-19 infection was observed in our analysis.

Downloads

Download data is not yet available.

References

References:

Flanigan KM. Duchenne and Becker muscular dystrophies. Neurologic clinics. 2014 Aug 1;32(3):671-88.

Veerapandiyan A, Wagner KR, Apkon S, et al. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID‐19 pandemic. Muscle Nerve. 2020 Apr 24.

Stratton AT, RO RI, Kupfer O, Carry T, Parsons J, Apkon S. Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic. J. Pediatr. Rehabil. Med. 2020 Oct 30.

Ehwerhemuepha L, Gasperino G, Bischoff N, et al. HealtheDataLab–a cloud computing solution for data science and advanced analytics in healthcare with application to predicting multi-center pediatric readmissions. BMC Med Inform Decis Mak. 2020 Jun 19;20(1):115.

Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging. 2011 Jan;4(1):67-76.

Downloads

Published

2021-12-20

Issue

Section

Clinic Stuff (Case Reports)